Researchers involved in a large cohort study from three major institutions are calling for broader use of trimodal therapy for muscle-invasive bladder cancer.
The American Gastroenterological Association published recommendations to help guide the management of hepatocellular carcinoma in the first- and second-line settings.
A review of patients who underwent posterior fossa tumor resections found no significant increase in perioperative complication or 30-day readmission rates. The study has not yet been peer reviewed.